Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Avantor, Inc. (AVTR)
Sector: Basic Materials; Industry: Specialty Chemicals

Avantor, Inc. provides products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-01-05 Brophy Gerard EVP, Biopharma Production Sell 70,969 $40.42 $2,868,918 Yes
2021-12-27 Couturier Christophe EVP, AMEA Sell 10,184 $41.63 $423,960 Yes
2021-12-22 Couturier Christophe EVP, AMEA Sell 66,434 $41.22 $2,738,700 Yes
2021-12-09 Couturier Christophe EVP, AMEA Sell 13,687 $40.14 $549,366 Yes
2021-12-01 GUPTA RAJIV Director Sell 100,000 $39.30 $3,930,000 No
2021-11-12 Vanderhaegen Frederic EVP, Europe Sell 140,804 $38.32 $5,395,482 Yes
2021-11-01 GUPTA RAJIV Director Sell 100,000 $40.31 $4,031,000 No
2021-10-01 GUPTA RAJIV Director Sell 100,000 $39.94 $3,994,000 No
2021-08-26 Eck Steven W SVP & Chief Accounting Officer Sell 17,383 $40.08 $696,711 No
2021-07-12 Natauri Jo Director Buy 300 $36.33 $10,900 No
2021-07-09 Bramwell James EVP, Strategic Partners Sell 18,331 $35.61 $652,828 No
2021-06-28 Couturier Christophe EVP, AMEA Sell 28,096 $35.73 $1,003,870 No
2021-06-25 GUPTA RAJIV Director Sell 68,605 $35.32 $2,423,129 No
2021-06-10 Stubblefield Michael President and CEO Sell 487,700 $32.13 $15,667,507 Yes
2021-05-27 Ohri Devashish EVP, IMEA Sell 100,000 $31.99 $3,199,000 Yes
2021-05-24 GUPTA RAJIV Director Sell 337,571 $31.66 $10,687,716 No
2021-05-24 Ohri Devashish EVP, IMEA Sell 9,124 $31.75 $289,687 Yes
2021-05-20 Miller Justin EVP & General Counsel Sell 18,488 $31.12 $575,347 No
2021-05-20 Couturier Christophe EVP, AMEA Sell 25,010 $31.13 $778,561 No
2021-05-20 Brophy Gerard EVP, Biopharma Production Sell 19,603 $31.10 $609,653 No
2021-05-11 Natauri Jo Director Sell 2,626,771 $30.68 $80,589,334 No
2019-09-25 Natauri Jo Director Sell 950 $14.00 $13,300 No
2019-09-25 GOLDMAN SACHS & CO. LLC 10%-Owner Sell 950 $14.00 $13,300 No
2019-09-25 Connolly Thomas Director Sell 950 $14.00 $13,300 Yes
2021-04-30 Ohri Devashish EVP, IMEA Sell 53,649 $32.58 $1,747,884 Yes
2021-04-12 Ohri Devashish EVP, IMEA Sell 100,160 $32.37 $3,242,179 Yes
2021-04-12 Vanderhaegen Frederic EVP, Europe Sell 27,075 $31.80 $860,997 No
2021-04-12 Bramwell James EVP, Strategic Partners Sell 2,505 $32.00 $80,160 No
2021-04-12 Miller Justin EVP & General Counsel Sell 102,895 $33.17 $3,412,916 Yes
2021-03-09 Vanderhaegen Frederic EVP, Europe Sell 10,000 $28.21 $282,100 No

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.